Carnegie Investment Counsel’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Buy
61,476
+4,604
+8% +$987K 0.26% 108
2026
Q1
$12.6M Buy
56,872
+3,323
+6% +$813K 0.25% 113
2025
Q4
$13.6M Buy
53,549
+357
+0.7% +$89.7K 0.25% 105
2025
Q3
$13.2M Sell
53,192
-3,505
-6% -$839K 0.25% 115
2025
Q2
$13.6M Buy
56,697
+373
+0.7% +$86.8K 0.27% 107
2025
Q1
$12M Sell
56,324
-864
-2% -$190K 0.28% 108
2024
Q4
$11.8M Buy
57,188
+833
+1% +$183K 0.34% 87
2024
Q3
$13.7M Buy
56,355
+1,647
+3% +$385K 0.4% 73
2024
Q2
$12M Buy
54,708
+2,880
+6% +$626K 0.37% 78
2024
Q1
$11.7M Buy
51,828
+2,131
+4% +$481K 0.36% 78
2023
Q4
$10.9M Sell
49,697
-224
-0.4% -$47.4K 0.37% 76
2023
Q3
$11M Buy
49,921
+576
+1% +$130K 0.42% 67
2023
Q2
$11.1M Buy
49,345
+3,077
+7% +$616K 0.41% 70
2023
Q1
$8.85M Buy
46,268
+1,736
+4% +$336K 0.35% 84
2022
Q4
$8.22M Sell
44,532
-2,990
-6% -$526K 0.35% 80
2022
Q3
$7.9M Sell
47,522
-3,829
-7% -$779K 0.38% 79
2022
Q2
$10.6M Sell
51,351
-1,298
-2% -$293K 0.48% 64
2022
Q1
$12.7M Buy
52,649
+1,503
+3% +$348K 0.46% 65
2021
Q4
$12.4M Buy
51,146
+10,142
+25% +$2.32M 0.41% 75
2021
Q3
$8.38M Buy
41,004
+645
+2% +$138K 0.32% 96
2021
Q2
$8.33M Buy
40,359
+2,939
+8% +$592K 0.31% 95
2021
Q1
$7.13M Buy
37,420
+827
+2% +$153K 0.3% 101
2020
Q4
$6.94M Sell
36,593
-161
-0.4% -$30K 0.31% 96
2020
Q3
$6.46M Buy
36,754
+322
+0.9% +$51.5K 0.33% 93
2020
Q2
$5.58M Buy
36,432
+1,120
+3% +$171K 0.32% 92
2020
Q1
$4.93M Buy
35,312
+8,242
+30% +$1.23M 0.34% 87
2019
Q4
$4.13M Buy
27,070
+5,725
+27% +$839K 0.24% 116
2019
Q3
$3.08M Buy
21,345
+12,074
+130% +$1.8M 0.2% 129
2019
Q2
$1.38M Buy
9,271
+2,899
+45% +$387K 0.09% 184
2019
Q1
$816K Buy
6,372
+61
+1% +$7.18K 0.06% 232
2018
Q4
$674K Sell
6,311
-7,438
-54% -$830K 0.06% 224
2018
Q3
$1.64M Buy
13,749
+6,390
+87% +$723K 0.13% 159
2018
Q2
$843K Buy
7,359
+201
+3% +$20.2K 0.06% 218
2018
Q1
$742K Sell
7,158
-297
-4% -$27K 0.06% 215
2017
Q4
$643K Sell
7,455
-830
-10% -$74K 0.06% 243
2017
Q3
$756K Sell
8,285
-400
-5% -$33.9K 0.09% 211
2017
Q2
$714K Buy
8,685
+2
+0% +$152 0.09% 209
2017
Q1
$663K Sell
8,683
-398
-4% -$27.5K 0.08% 208
2016
Q4
$620K Sell
9,081
-4,548
-33% -$308K 0.08% 204
2016
Q3
$941K Sell
13,629
-994
-7% -$70.2K 0.14% 159
2016
Q2
$1.03M Buy
14,623
+1,209
+9% +$84.7K 0.14% 156
2016
Q1
$953K Buy
13,414
+3,113
+30% +$211K 0.15% 159
2015
Q4
$713K Buy
10,301
+1,751
+20% +$127K 0.12% 171
2015
Q3
$583K Buy
8,550
+1,330
+18% +$87.9K 0.1% 186
2015
Q2
$465K Buy
7,220
+1,950
+37% +$132K 0.08% 203
2015
Q1
$366K Buy
5,270
+1,250
+31% +$82.5K 0.06% 221
2014
Q4
$268K Buy
4,020
+175
+5% +$10.8K 0.05% 236
2014
Q3
$207K Hold
3,845
0.04% 279
2014
Q2
$206K Buy
+3,845
New +$198K 0.05% 224

Other funds holding STE

Carnegie Investment Counsel's STE Position: Q2 2026 in Review

Carnegie Investment Counsel increased its Steris (STE) stake by 8.1% in Q2 2026, buying an estimated $987K and bringing the position to 61,476 shares worth $12.9M. The position accounts for 0.26% of the portfolio, ranked #108.

Carnegie Investment Counsel first reported a position in STE in Q2 2014 and has held it in 49 quarters since. The position peaked at $13.7M in Q3 2024. 425 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Carnegie Investment Counsel held 61,476 shares of Steris worth $12.9M as of Q2 2026.
  • Carnegie Investment Counsel bought 4,604 Steris shares in Q2 2026, an estimated $987K.
  • Steris made up 0.26% of Carnegie Investment Counsel's portfolio in Q2 2026, its #108 holding.
  • Carnegie Investment Counsel first reported a position in Steris in Q2 2014 and has held it in 49 quarters since.
  • Carnegie Investment Counsel's Steris position peaked at $13.7M in Q3 2024.
  • 425 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.